Compare Stocks: CNXU, INMD, AVR, and SIBN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVR Anteris Technologies Global	$8.93 +0.7%	$9.15	$3.30 ▼ $11.06	$869.26M	1.78	1.17 million shs	446,994 shs
CNXU Conexeu Sciences	$7.97 +9.0%	$10.22	$6.85 ▼ $18.79	$213.28M	N/A	112,743 shs	179,673 shs
INMD InMode	$15.20 -0.2%	$14.65	$12.72 ▼ $16.74	$873.70M	1.89	901,154 shs	347,695 shs
SIBN SiBone	$18.95 -0.3%	$16.91	$11.48 ▼ $21.89	$840.43M	0.66	622,454 shs	246,715 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVR Anteris Technologies Global	-3.27%	+10.19%	-5.24%	+22.34%	+139.08%
CNXU Conexeu Sciences	-1.75%	-18.69%	-29.30%	+730,999,900.00%	+730,999,900.00%
INMD InMode	+0.59%	+0.13%	+0.53%	+8.40%	+7.10%
SIBN SiBone	+1.06%	+5.32%	+6.44%	+30.14%	+25.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVR Anteris Technologies Global	$8.93 +0.7%	$9.15	$3.30 ▼ $11.06	$869.26M	1.78	1.17 million shs	446,994 shs
CNXU Conexeu Sciences	$7.97 +9.0%	$10.22	$6.85 ▼ $18.79	$213.28M	N/A	112,743 shs	179,673 shs
INMD InMode	$15.20 -0.2%	$14.65	$12.72 ▼ $16.74	$873.70M	1.89	901,154 shs	347,695 shs
SIBN SiBone	$18.95 -0.3%	$16.91	$11.48 ▼ $21.89	$840.43M	0.66	622,454 shs	246,715 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVR Anteris Technologies Global	-3.27%	+10.19%	-5.24%	+22.34%	+139.08%
CNXU Conexeu Sciences	-1.75%	-18.69%	-29.30%	+730,999,900.00%	+730,999,900.00%
INMD InMode	+0.59%	+0.13%	+0.53%	+8.40%	+7.10%
SIBN SiBone	+1.06%	+5.32%	+6.44%	+30.14%	+25.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVR Anteris Technologies Global	2.60	Moderate Buy	$16.00	79.17% Upside
CNXU Conexeu Sciences	2.50	Moderate Buy	$20.00	150.94% Upside
INMD InMode	2.00	Hold	$16.00	5.26% Upside
SIBN SiBone	2.71	Moderate Buy	$24.17	27.53% Upside

Current Analyst Ratings Breakdown

Latest CNXU, INMD, AVR, and SIBN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/6/2026	INMD InMode	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/5/2026	SIBN SiBone	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/4/2026	SIBN SiBone	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$24.00 ➝ $25.00
8/4/2026	SIBN SiBone	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$18.00 ➝ $20.00
8/4/2026	SIBN SiBone	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$21.00 ➝ $23.00
7/28/2026	SIBN SiBone	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$24.00
7/28/2026	SIBN SiBone	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$24.00
7/21/2026	SIBN SiBone	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/16/2026	SIBN SiBone	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$18.00 ➝ $21.00
7/2/2026	SIBN SiBone	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/29/2026	CNXU Conexeu Sciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold

(Data available from 8/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVR Anteris Technologies Global	$2.24M	387.72	N/A	N/A	($0.01) per share	-893.00
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A
INMD InMode	$370.49M	2.36	$1.50 per share	10.15	$10.94 per share	1.39
SIBN SiBone	$200.93M	4.18	N/A	N/A	$4.11 per share	4.61

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVR Anteris Technologies Global	-$94.14M	-$1.95	N/A	N/A	N/A	-4,619.27%	-110.36%	-92.25%	N/A
CNXU Conexeu Sciences	-$3.92M	-$0.11	N/A	N/A	N/A	N/A	N/A	N/A	N/A
INMD InMode	$93.83M	$1.23	12.36	N/A	N/A	20.69%	11.99%	10.60%	10/28/2026 (Estimated)
SIBN SiBone	-$18.90M	-$0.34	N/A	N/A	N/A	-6.85%	-8.23%	-6.07%	N/A

Latest CNXU, INMD, AVR, and SIBN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2026	Q2 2026 TU	AVR Anteris Technologies Global	-$0.2073	-$0.30	-$0.0927	-$0.30	$1.50 million	$1.01 million
8/5/2026	Q2 2026	INMD InMode	$0.3460	$0.35	+$0.0040	$0.29	$94.89 million	$95.59 million
8/3/2026	Q2 2026	SIBN SiBone	-$0.1495	-$0.09	+$0.0595	-$0.09	$55.34 million	$56.01 million
6/15/2026	Q2 2026	CNXU Conexeu Sciences	N/A	-$0.11	N/A	-$0.11	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVR Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
INMD InMode	N/A	N/A	N/A	N/A	N/A
SIBN SiBone	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVR Anteris Technologies Global	N/A	20.93	20.93
CNXU Conexeu Sciences	N/A	14.93	14.93
INMD InMode	N/A	8.18	7.28
SIBN SiBone	0.20	9.15	7.55

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVR Anteris Technologies Global	N/A
CNXU Conexeu Sciences	N/A
INMD InMode	68.04%
SIBN SiBone	98.11%

Insider Ownership

Company	Insider Ownership
AVR Anteris Technologies Global	4.50%
CNXU Conexeu Sciences	N/A
INMD InMode	6.92%
SIBN SiBone	4.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVR Anteris Technologies Global	138	97.34 million	92.96 million	N/A
CNXU Conexeu Sciences	4	26.76 million	N/A	N/A
INMD InMode	480	57.48 million	53.50 million	Optionable
SIBN SiBone	350	44.35 million	42.58 million	Optionable

CNXU, INMD, AVR, and SIBN Headlines

Recent News About These Companies

SiBone $SIBN Shares Bought by Dimensional Fund Advisors LP

August 11 at 3:35 AM | marketbeat.com

SiBone (NASDAQ:SIBN) Given Consensus Rating of "Moderate Buy" by Brokerages

August 9, 2026 | americanbankingnews.com

SiBone (NASDAQ:SIBN) Receives Consensus Rating of "Moderate Buy" from Analysts

August 9, 2026 | marketbeat.com

SiBone $SIBN Shares Purchased by Sei Investments Co.

August 7, 2026 | marketbeat.com

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

August 6, 2026 | zacks.com

Insider Selling: SiBone (NASDAQ:SIBN) Director Sells $369,200.00 in Stock

August 6, 2026 | insidertrades.com

Renaissance Technologies LLC Increases Stake in SiBone $SIBN

August 6, 2026 | marketbeat.com

SiBone (NASDAQ:SIBN) Earns Buy Rating from Truist Financial

August 6, 2026 | americanbankingnews.com

SiBone (NASDAQ:SIBN) Director Jeffrey Dunn Sells 20,000 Shares

August 5, 2026 | marketbeat.com

SiBone's (SIBN) Buy Rating Reaffirmed at Truist Financial

August 4, 2026 | marketbeat.com

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

August 3, 2026 | zacks.com

SiBone Q2 Earnings Call Highlights

August 3, 2026 | marketbeat.com

SiBone (NASDAQ:SIBN) Posts Earnings Results, Beats Estimates By $0.06 EPS

August 3, 2026 | marketbeat.com

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance

August 3, 2026 | globenewswire.com

SiBone (SIBN) Expected to Post Quarterly Earnings on Monday

August 2, 2026 | americanbankingnews.com

SiBone (NASDAQ:SIBN) Rating Increased to Strong-Buy at UBS Group

July 29, 2026 | marketbeat.com

SiBone (NASDAQ:SIBN) Shares Gap Up - Still a Buy?

July 28, 2026 | marketbeat.com

SI-BONE Inc.

July 27, 2026 | barrons.com

SiBone (SIBN) Projected to Release Quarterly Earnings on Monday

July 27, 2026 | marketbeat.com

First Light Asset Management LLC Has $67.61 Million Stock Holdings in SiBone $SIBN

July 27, 2026 | marketbeat.com

Granahan Investment Management LLC Boosts Holdings in SiBone $SIBN

July 25, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU, INMD, AVR, and SIBN Company Descriptions

Anteris Technologies Global NASDAQ:AVR

$8.93 +0.06 (+0.68%)

Closing price 04:00 PM Eastern

Extended Trading

$9.12 +0.19 (+2.17%)

As of 04:38 PM Eastern

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Conexeu Sciences NASDAQ:CNXU

$7.97 +0.66 (+9.03%)

Closing price 04:00 PM Eastern

Extended Trading

$8.06 +0.09 (+1.07%)

As of 05:57 PM Eastern

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

InMode NASDAQ:INMD

$15.20 -0.03 (-0.20%)

Closing price 04:00 PM Eastern

Extended Trading

$15.22 +0.02 (+0.10%)

As of 04:10 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

SiBone NASDAQ:SIBN

$18.95 -0.05 (-0.26%)

Closing price 04:00 PM Eastern

Extended Trading

$18.94 0.00 (-0.03%)

As of 04:10 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CNXU, INMD, AVR, and SIBN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CNXU, INMD, AVR, and SIBN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CNXU, INMD, AVR, and SIBN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU, INMD, AVR, and SIBN Company Descriptions

Anteris Technologies Global NASDAQ:AVR

Conexeu Sciences NASDAQ:CNXU

InMode NASDAQ:INMD

SiBone NASDAQ:SIBN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CNXU, INMD, AVR, and SIBN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CNXU, INMD, AVR, and SIBN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CNXU, INMD, AVR, and SIBN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU, INMD, AVR, and SIBN Company Descriptions

Anteris Technologies Global NASDAQ:AVR

Conexeu Sciences NASDAQ:CNXU

InMode NASDAQ:INMD

SiBone NASDAQ:SIBN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools